Given that RANKL and RANK are expressed in dystrophic hearts and that mdx mice show signs of cardiac hypertrophy at 10 months of age, we investigated whether inhibiting RANKL would modulate cardiac hypertrophy and contractility in dystrophic mice. This evidence concerns the gene TNFSF11 and cardiac hypertrophy.